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Abstract
Objective: In this work we evaluated the 5-year incidence of hypercholesterolemia, in a sample
of cardiovascular disease free adult men and women from Greece. We also evaluated the
association of several socio-demographic, dietary and lifestyle habits on the incidence of this
disorder.
Methods: 1514 men and 1528 women (>18 y) without any clinical evidence of cardiovascular
disease, living in Attica area, Greece, were enrolled in the ATTICA study from May 2001 to
December 2002. The sampling was random, multi-stage, and included information about various
socio-demographic, lifestyle (diet, exercise, smoking etc), biological (lipids, and inflammatory
markers), and clinical characteristics of the participants. In 2006, a group of experts performed the
5-year follow-up through telephone calls or personal visits (941 of the 3042 (31%) participants
were lost to follow-up). Hypercholesterolemia, among people who had normal blood lipids at initial
examination, was defined as fasting total cholesterol levels > 200 mg/dl or use of lipids lowering
agents (NCEP ATPIII).
Results: The 5-year incidence of hypercholesterolemia was 23.7% (n = 127) in men and 17.7% (n
= 110) in women (p for gender differences < 0.001). Multi-adjusted logistic regression analysis
which revealed that increased age (odds ratio = 1.05, p < 0.001), waist circumference (odds ratio
= 1.02, p = 0.03), fasting blood glucose (odds ratio = 1.01, p = 0.08) and apolipoprotein B (odds
ratio = 1.02, p = 0.001) levels, were the most significant baseline predictors of developing
hypercholesterolemia within a 5-year period.
Conclusion: Incidence of hypercholesterolemia was high in both genders, emphasizing the burden
of this disorder at population level. Aging, increased waist circumference, fasting blood glucose and
apolipoprotein B levels were the most significant baseline predictors of hypercholesterolemia.
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Introduction
Hypercholesterolemia, the presence of high levels of cho-
lesterol in the blood, although not a disease, it is a meta-
bolic condition that can be secondary to many diseases,
most notably cardiovascular disease [1-3]. The most com-
mon cause of elevated serum cholesterol is eating foods
that are rich in saturated fats or contain high levels of cho-
lesterol. Elevated cholesterol also can be caused by an
underlying disease that raises blood cholesterol levels
such as diabetes mellitus, kidney disease, liver disease, or
hypothyroidism. It also can be caused by an inherited dis-
order in which lipoprotein is not metabolized properly by
the body. Obesity, in its various manifestations, which
generally results from eating a diet high in fat, also can
lead to elevated cholesterol levels in the blood [4,5]. As
the serum levels of cholesterol increases so did the risk of
having coronary heart disease (CHD). It has been sug-
gested that the risk for CHD is approximately five times
higher among persons having cholesterol levels of 300
mg/dl or more compared to those with cholesterol levels
below 200 mg/dl [1]. According to the Center for Disease
Control and Prevention [3], high cholesterol affects about
20% of adults over the age of 20 in the USA, while the
highest prevalence occurs in elderly women. The World
Health Organization (WHO) [5] reports that high choles-
terol contributes to 56% of cases of CHD worldwide and
causes about 4.4 million deaths each year. In most parts
of the world, the number of female deaths attributed to
high cholesterol is slightly higher than the number of
male deaths. However, despite these data, detailed infor-
mation from various parts of the world regarding the dis-
tribution and incidence of abnormal blood lipids is sparse
in the literature.
Given the lack of current data regarding the incidence of
high blood lipids levels in European and, especially south
European, populations, like the Greek, the 5-year inci-
dence of hypercholesterolemia (i.e. high total serum cho-
lesterol levels) and its determinants was investigated, in a




The "ATTICA" epidemiological study [6,7] was carried out
in the province of Attica (including 78% urban and 22%
rural areas) during 2001–2002. The sampling anticipated
enrolling only one participant per household; it was ran-
dom, multistage and based on the age (5 stages), sex (2
stages) distribution of the Attica region (27 stages, census
of 2001). Also, all people living in institutions were
excluded from the study. During the aforementioned
period, 4056 inhabitants from the above area were
selected to enrol into the study; of them, 3042 agreed to
participate (75% participation rate), 1514 of the partici-
pants were men and 1528 were women. All participants
interviewed by trained personnel (cardiologists, general
practitioners, dieticians and nurses) who used a standard
questionnaire.
Baseline measurements
The baseline evaluation included information about:
socio-demographic characteristics (age, sex, mean annual
income and years of school, as proxy of social status), per-
sonal and family history of hypertension, hypercholester-
olemia and diabetes, dietary and other lifestyle habits,
such as smoking status, and physical activity. In particular,
the evaluation of the nutritional habits was based on a
validated semi-quantitative food-frequency questionnaire
[8]. All participants were asked to report the average
intake (per week or day) of several food items that they
consumed (during the last 12 months). Then, the fre-
quency of consumption was quantified approximately in
terms of the number of times a month a food was con-
sumed. Any type of alcohol consumption was measured
in wineglasses (100 ml) and quantified by ethanol intake
(in g per day). In order to describe overall diet composite
scores were used, which are necessary for the evaluation of
epidemiological associations. Thus, a special Mediterra-
nean diet score was used (range 0–55) that is based on the
rationale of the Mediterranean dietary pyramid [9].
Energy intake was calculated through food-composition
tables. Smokers were defined as those who were smoking
at least one cigarette per day during the past year or had
recently stopped smoking (during a year); the rest of the
participants were defined as non-smokers. For the ascer-
tainment of physical activity status the International Phys-
ical Activity Questionnaire was used (IPAQ, [10]), as an
index of weekly energy expenditure using frequency
(times per week), duration (in minutes per time) and
intensity of sports or other habits related to physical activ-
ity (in expended calories per time). Participants who did
not report any physical activities were defined as physi-
cally inactive (sedentary lifestyle). Body mass index (BMI)
was measured as weight (in kilograms) divided by stand-
ing height (in meters squared). Obesity was defined as
BMI greater than 29.9 Kg/m2. Waist (in cm) and hip (in
cm) circumferences were also measured. Arterial blood
pressure (3 recordings) was measured at the end of the
physical examination with subject in sitting position. All
participants were at least 30 minutes at rest. Participants
whose average blood pressure levels were greater or equal
to 140/90 mmHg or were under antihypertensive medica-
tion were classified as having hypertension, as it is com-
monly done in epidemiological studies. Blood samples
were collected from the antecubital vein between 8 to 10
a.m., in a sitting position after 12 hours of fasting and
alcohol abstinence. Total serum cholesterol, HDL-choles-
terol, and triglycerides were measured using chromato-
graphic enzymic method in a Technicon automaticLipids in Health and Disease 2008, 7:11 http://www.lipidworld.com/content/7/1/11
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analyser RA-1000 (Dade Behring, Marburg, Germany).
Hypercholesterolemia was defined as total cholesterol lev-
els greater than 200 mg/dl or the use of lipids lowering
agents (NCEP ATPIII [11]). HDL cholesterol was deter-
mined after precipitation of the Apolipoprotein B con-
taining lipoproteins with dextran-magnesium-chloride.
Serum for the measurement of these lipids was harvested
immediately after admission. LDL cholesterol calculated
using the Friedewald formula: {total cholesterol} – {HDL
cholesterol} – 1/5 (triglycerides) (only in people who had
triglycerides levels lower than 250 mg/dl). The intra and
inter-assay coefficients of variation of cholesterol levels
did not exceed 9%, triglycerides 4% and HDL 4%. Diabe-
tes mellitus as a fasting blood sugar > 125 mg/dl or the use
of antidiabetic medication. Details about the ATTICA
study may be found elsewhere [6].
Follow-up
During 2006, the ATTICA study's investigators performed
the 5-year follow-up. Of the 3042 initially enrolled partic-
ipants, 1012 men and 1035 women were alive at the time
of the follow-up (69% participation rate), while 32
(2.1%) men and 22 (1.4%) women died during the 5-year
period. Of the participants that they did not participate in
the re-examination (n = 995), 75% were not found
because of missing or wrong addresses and telephone
numbers, and 25% denied being re-examined. No signifi-
cant differences were observed between those who were
lost to follow-up and the rest of the participants regarding
sex (p = 0.99), and baseline age (p = 0.78), education level
in years of school (p = 0.67), as well as presence of hyper-
tension (p = 0.12), diabetes (p = 0.27) and hypercholeste-
rolemia (p = 0.12).
The re-examination was based on telephone interviews
(80% of the participants) and on face-to-face interviews
when the telephone number was not available. The re-
examination included information about: (a) vital status
(death from any cause or due to cardiovascular disease),
or development of CHD (including myocardial infarc-
tion, angina pectoris, other identified forms of ischemia -
WHO-ICD coding 410–414.9, 427.2, 427.6-, heart failure
of different types, and chronic arrhythmias -WHO-ICD
coding 400.0–404.9, 427.0–427.5, 427.9-) or develop-
ment of stroke (WHO-ICD coding 430–438), (b) devel-
opment of hypertension, hypercholesterolemia, and
diabetes, among people who did not have these disorders
at baseline, as well as management of these conditions,
(c) assessment of body weight and height, and (d) lifestyle
habits, including physical activity and smoking status, as
well as various food groups intake. For the present analy-
sis people who have been defined as having hypercholes-
terolemia at baseline examination (n = 1140) were
excluded. Thus, taking into account those who were lost
to follow-up and those who had high cholesterol levels at
baseline examination, data from 1157 participants were
analyzed in this work.
Statistical analysis
Continuous variables are presented as mean values ±
standard deviation. Categorical variables are presented as
absolute and relative frequencies. Associations between
categorical variables were tested using the chi-squared
test. Comparisons of mean values of normally distributed
continuous variables between those who developed
hypercholesterolemia and the rest of the participants were
performed using Student's t-test, after controlling for
equality of variances. Since the exact time to event (i.e.,
development hypercholesterolemia) was not available,
the relative risks of developing this disorder during the 5-
year period, according to the participants' baseline charac-
teristics, were estimated using the odds ratios (OR) and
their corresponding 95% confidence intervals (CIs)
through stepwise multiple logistic regression analysis. We
used 5% as the cut-off for the probability of entering a var-
iable in the model and 10% as the cut-off for the proba-
bility of removing a variable from the model. The
probabilities were calculated using the Wald test. Interac-
tions between sex and other covariates were tested in all
steps, and when they were significant, remained in the
final model. Deviance residuals were used to evaluate
model's goodness-of-fit and -2loglikelihood of the initial
and final model were also calculated. Finally, to further
explore which of the baseline measurements was the best
predictor of hypercholesterolemia a discriminant analysis
was performed using the Area Under the Receiver Operat-
ing Characteristic Curve (AUC, higher values of the AUC,
better discriminating ability). Moreover, positive and neg-
ative predictive values were also calculated for the predic-
tors that remained significant in the multiple logistic
regression analysis. All reported P-values are based on
two-sided tests and compared to a significance level of
5%. SPSS version 14 (Statistical Package for Social Sci-
ences, SPSS Inc, Chicago, IL, U.S.A.) software was used for
all the statistical calculations.
Results
The 5-year incidence of hypercholesterolemia was found
23.7% (n = 127) in men and 17.7% (n = 110) in women
(p for gender differences < 0.001). Thus, the annual inci-
dence of hypercholesterolemia is calculated to be 474 new
cases per 10,000 men and 354 new cases per 10,000
women participants. A linear trend was observed between
incidence of hypercholesterolemia and age – group of the
participants (p for trend < 0.001, Table 1). In particular,
men who were >65 y at baseline examination experience
5.5-times higher risk of developing hypercholesterolemia
compared to those who were under 35 y, while women
over 65 y at baseline experience 15.2-times higher risk of
developing hypercholesterolemia compared to < 35 y oldLipids in Health and Disease 2008, 7:11 http://www.lipidworld.com/content/7/1/11
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participants. Furthermore, the men-to-women incidence
rate ratio is 1.34; however, a gradual change is observed at
the age of 55 y and older, where older women seem to be
more prominent to develop hypercholesterolemia com-
pared to men (Table 1). A strong association was also
observed between baseline obesity status and incidence
rates in both genders (p < 0.001). In particular, new cases
of hypercholesterolemia were 16%, 26% and 32% among
normal weight, overweight and obese men, as well 12%,
31% and 23% among normal weight, overweight and
obese women, respectively. Additionally, incidence rates
of hypercholesterolemia were 2-times higher in women
who had had hypertension compared to normotensives
(i.e. 28.7% vs. 14.8%, p < 0.001), while no differences
regarding the incidence of hypercholesterolemia was
observed between hypertensive and normotensive men
(i.e. 25.9% vs. 22.1%, p = 0.34). Finally, incidence of
hypercholesterolemia was almost 3-times higher in dia-
betic women (i.e. 45.5% vs. 16.7%, p < 0.001), and 2 –
times higher among diabetic men compared to those who
had normal glucose levels at baseline examination (i.e.
45.9% vs. 22.0%, p = 0.001).
Demographic, clinical and behavioural characteristics of
the participants by hypercholesterolemia status are pre-
sented in Table 2. Although, multiple comparisons are
made in the results presented in Table 2, and, conse-
quently the probability of false positives findings (i.e. p-
value) increases dramatically, it is noticeable to mention
that people who developed hypercholesterolemia within
the 5-year period were more likely to be older men, with
increased ethanol intake, higher arterial blood pressure
levels, increased anthropometric indices, and diabetic, at
baseline examination. Of the anthropometric indices
waist circumference seems to have the best discriminating
ability (AUC = 0.65), followed by BMI (AUC = 0.64) and
hip circumference (AUC = 0.60). Moreover, from the
baseline blood lipids measurements ROC analysis
showed that apolipoprotein B (AUC = 0.75), followed by
triglycerides (AUC = 0.727), total cholesterol (AUC =
0.70), LDL-cholesterol (AUC = 0.62), HDL-cholesterol
(AUC = 0.55) and apolipoprotein AI (AUC = 0.54) were
all significantly associated with the development of hyper-
cholesterolemia.
However, all the aforementioned comparisons are prone
to residual confounding; therefore we performed multi-
adjusted logistic regression analysis which revealed that
increased age (p < 0.001), waist circumference (p = 0.03),
fasting glucose (p = 0.08) and apolipoprotein B (p =
0.001) levels, were the most significant baseline predic-
tors of developing hypercholesterolemia within a 5-year
period (Table 3). Mediterranean diet score was inversely
associated with the development of hypercholesterolemia
(see initial model), but the relationship became insignifi-
cant in the final model because of age and sex differences.
Stratified analysis revealed that adherence to the Mediter-
ranean diet was protective only in middle aged (35–55 y)
women (relative risk = 0.92, 95% CI 0.87–0.97).
Nevertheless, it is likely that the aforementioned results
are explained by the cross-sectional associations of choles-
terol and the other variables, like age, sex, blood glucose
levels etc. Thus, to further evaluate which factors predict
incidence of hypercholesterolemia beyond that of base-
line cholesterol, we also included baseline serum choles-
terol in the multivariable analyses. Findings suggest that
only age, and waist circumference remained significant,
after adjusting for baseline cholesterol levels (Table 3),
indicating that the predictive ability of the other factors
presented in the final model were mainly explained by the
baseline differences in cholesterol levels.
Additionally, cut-off point analysis showed that the posi-
tive predictive value for age greater than 45 y was 37%
(95%CI 35% to 39%), the positive predictive value for
waist circumference greater than 95/82 cm (men/women)
was 30% (95%CI 28% to 32%), the positive predictive
value for fasting glucose greater than 100 mg/dl was 30%
(95%CI 28% to 32%) and the positive predictive value for
apolipoprotein B greater than 100 mg/dl was 34%
(95%CI 31% to 37%). The cut-off points used are the
optimal values that discriminate hypercholesterolemic
from those who had normal total cholesterol levels at fol-
Table 1: Five-year incidence of hypercholesterolemia in men and women, by age group.
Men Women
# People participated in the follow-up 536 621
Age at baseline 5-year incidence of hypercholesterolemia Men-to-women ratio
<35 y 6.90% 4.00% 1.73
35–45 y 18.20% 5.00% 3.64
45–55 y 29.70% 25.10% 1.18
55–65 y 37.80% 57.60% 0.66
> 65 y 38.10% 60.90% 0.63
Overall 23.70% 17.70% 1.34Lipids in Health and Disease 2008, 7:11 http://www.lipidworld.com/content/7/1/11
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low-up, as derived from ROC analysis. Moreover, pres-
ence of all the aforementioned baseline characteristics
(i.e., age > 45 y, waist circumference > 95/82 cm (men/
women), fasting glucose >100 mg/dl and apolipoprotein
B > 100 mg/dl) 20.2-fold the risk of developing hypercho-
lesterolemia within the 5-year period (95% CI 18.7 to
21.7). In addition, all these factors explained the 22.3%
(Negelkerke R-square = 0.223) of the estimated model's
variability.
Discussion
In this work the 5-year incidence rate of hypercholestero-
lemia was evaluated. In particular, approximately one out
of four men and one out of five women that participated
in the ATTICA study, developed hypercholesterolemia
within this period. The annual incidence rate is about 5%
in men and 4% in women, which means that about
900,000 men and women from a total population of 6,5
million people who had had normal cholesterol levels at
baseline, developed hypercholesterolemia during the pre-
ceding 5 years. Of the baseline factors, increased age, high
waist circumference, fasting blood glucose and apolipo-
protein B levels, were the most significant determinants of
developing hypercholesterolemia.
In the baseline examination (2001–2002), 46% of men
and 40% of women had high total cholesterol levels (i.e.,
>200 mg/dl), and based on these figures it was speculated
that about 3,0 million men and women had hypercholes-
terolemia, in Greece. Based on the present follow up find-
ings, it could be speculated that approximately 180,000
people developed hypercholesterolemia each year, a fact
that makes this disorder a very serious problem for the
health status of the reference population. The National
Health and Nutrition Examination Survey (NHANES) III
study [12] reported that 52% of non-Hispanic white men
and 49% of women in USA, had total blood cholesterol
levels over 200 mg/dl, rates that are similar to those
reported by the ATTICA study. Moreover, several studies
have shown that a higher percentage of women than men
have total blood cholesterol of 200 mg/dl or higher,
beginning at age 50 [13,14], which was also observed in
the present work since the incidence rate ratio of hyperc-
holesterolemia was higher in women after the age of 55 y
(Table 1). Taking into account that the prevalence of
hypercholesterolemia in the baseline evaluation of the
ATTICA study was about 45%, the Seven Countries Study
investigators' [15] reported that in 1980s about 40% of
middle-aged Athenian men and women had high total
Table 2: Baseline characteristics of the ATTICA study's participants according to the 5-year incidence of hypercholesterolemia.
Status at 5-year follow – up
Baseline factors: Normal total cholesterol (n = 920) Hypercholesterolemia (n = 237) P
Age (y) 39 ± 13 50 ± 13 0.001
Male sex, % 44% 54% 0.01
Years of school 13 ± 3 12 ± 4 0.01
Smokers, % 42% 37% 0.21
Physically inactive subjects, % 56% 61% 0.16
Mediterranean diet score (0–55) 27 ± 7 25 ± 6 0.001
Ethanol intake (g/d) 7.0 ± 10 12.2 ± 12 0.001
Systolic blood pressure, mmHg 118 ± 17 125 ± 17 0.001
Diastolic blood pressure, mmHg 77 ± 8 80 ± 10 0.04
Hypertensive subjects, % 23% 33% 0.001
Total cholesterol, mg/dl 163 ± 22 177 ± 19 <0.001
HDL-cholesterol, mg/dl 49 ± 13 47 ± 15 0.06
LDL-cholesterol, mg/dl 98 ± 22 106 ± 21 0.001
Apolipoprotein AI, mg/dl 154 ± 89 149 ± 101 0.02
Apolipoprotein B, mg/dl 88 ± 37 106 ± 23 0.001
Triglycerides, mg/dl 85 ± 47 127 ± 71 0.001
Diabetic subjects, % 3% 11% <0.001
Fasting glucose, mg/dl 89 ± 19 93 ± 19 0.001
Obese subjects, % 15% 22% 0.008
Body mass index, kg/m2 25 ± 5 28 ± 4 0.001
Waist, cm
Men 95 ± 11 100 ± 11 0.001
Women 80 ± 12 86 ± 12 0.001
Hip, cm
Men 105 ± 9 106 ± 9 0.10
Women 101 ± 11 104 ± 11 0.06
Data are expressed as mean ± SD or relative frequencies.
P-values are not corrected for multiple comparisons.Lipids in Health and Disease 2008, 7:11 http://www.lipidworld.com/content/7/1/11
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cholesterol levels, while the "Athens Study" investigators
[16] also in early 1980s reported similar results, it is now
evident that there is a long-term increasing trend of hyper-
cholesterolemia in Greece. This may attribute to the
adherence of a more Westernised lifestyle that observed in
Greece during the past two decades, which includes con-
sumption of high – fat foods, adoption of sedentary life
and increased cigarette smoking [15]. Regarding other
populations, in a study conducted in another Mediterra-
nean country, Portugal [17], the investigators reported an
incidence of hypercholesterolemia equal to 55.9 cases per
10,000 inhabitants, while there was a higher incidence in
men than in women up to the age of 54, but at more
advanced ages this relationship was reversed. Although
the incidence rates are much lower than those observed in
the present study (however, the definition of hypercholes-
terolemia varied from the one used in this work), a similar
trend was observed regarding the men-to-women ratio.
Data from the national Nutrition Examination Survey
conducted in US from 2001 to 2002, the incidence of
combined hypertension and hypercholesterolemia
(defined as LDL-cholesterol > 130 mg/dl) was 20% in
women and 16% in men, ranging from 1.9% in those
aged 20 to 29 years to 56% in those aged greater than 80
years [18]. The latter study underlined the crucial role of
hypertension in combination with high blood lipids lev-
els, which also observed in our study, too.
Oster et al., [19] reported that depending on age, gender,
and initial BMI level, a sustained 10% weight loss would
reduce the expected number of years of life with hyperc-
holesterolemia by 0.3 to 0.8, emphasizing the role of
body weight on the development of hypercholestero-
lemia. In the present work it was observed a 2-times
higher incidence of hypercholesterolemia among obese
individuals compared to normal weight, in both genders.
Moreover, waist circumference was one of the most signif-
icant predictors of 5-year incidence of hypercholestero-
lemia (Table 3); a 10 cm difference in baseline waist
circumference levels was associated with 22% (i.e. 1.0210)
higher risk of hypercholesterolemia within the 5-year
period. It is notable that waist circumference was the best
predictor among all anthropometric measurements.
Some recent studies have shown that apolipoproteins,
and especially apolipoprotein-B/apolipoprotein-AI ratio,
predicts cardiovascular risk better than any of the choles-
terol indexes [20,21]. It is known that apolipoprotein-B is
a primary apolipoprotein of low density lipoprotein and
it is responsible for carrying cholesterol to tissues. A recent
literature-based meta-analysis showed that compared to
Table 3: Results from multiple logistic regression analysis that evaluated socio-demographic, lifestyle, biological, clinical baseline 
characteristics in relation to 5-year incidence of hypercholesterolemia, in the ATTICA study participants.
Initial model Odds ratio 95% Confidence Interval
Age (per 1 year) 1.05 1.03–1.07
Male vs. females 1.18 0.73–1.87
Waist (per 1 cm) 1.01 0.99–1.03
Years of school (per 1 year) 1.03 0.97–1.09
Fasting blood glucose (per 1 mg/dl) 0.99 0.98–1.01
Total cholesterol (per 1 mg/dl) 1.02 1.00–1.03
Apolipoprotein B (per 1 mg/dl) 1.02 1.00–1.03
Apolipoprotein AI (per 1 mg/dl) 1.00 0.99–1.01
Systolic blood pressure (per 1 mmHg) 1.01 0.99–1.03
Diastolic blood pressure (per 1 mmHg) 0.99 0.97–1.02
Family history of hypercholesterolemia (y/n) 1.18 1.00–1.38
Energy intake (per 100 kcal) 1.02 0.98–1.05
Physically active vs. physically inactive 0.88 0.59–1.32
Smokers vs. non-smokers 1.06 0.79–4.09
Mediterranean diet score (per 1 unit) 0.94 0.90–0.97
Ethanol intake (per 1 g/d) 1.03 1.00–1.07
Final model
Age (per 1 year) 1.05 1.04–1.07
Waist (per 1 cm) 1.02 1.01–1.03
Fasting blood glucose (per 1 mg/dl) 1.01 0.99–1.03
Apolipoprotein B (per 1 mg/dl) 1.02 1.01–1.03
Final model also adjusted for baseline total serum cholesterol levels
Age (per 1 year) 1.04 1.03–1.06
Waist (per 1 cm) 1.01 1.00–1.02
Fasting blood glucose (per 1 mg/dl) 0.99 0.98–1.01
Apolipoprotein B (per 1 mg/dl) 1.005 0.99–1.01Lipids in Health and Disease 2008, 7:11 http://www.lipidworld.com/content/7/1/11
Page 7 of 8
(page number not for citation purposes)
participants in the lowest tertile of apolipoprotein-B,
those in the highest had 99% increased risk of having
CHD [21]. Several investigators have also associated some
genetic variations of apolipoprotein-B with the develop-
ment of hypercholesterolemia and CHD [22-25]. In the
present analysis apolipoprotein B was the most significant
predictor of hypercholesterolemia among all baseline
measurements, including blood lipids. Moreover, 34% of
the participants with apolipoprotein B levels greater than
100 mg/dl developed hypercholesterolemia within a 5-
year period.
Fasting blood glucose levels were also a significant predic-
tor of hypercholesterolemia. Particularly, 30% of partici-
pants who had glucose levels greater than 100 mg/dl at
baseline examination developed hypercholesterolemia
during the aforementioned period. It is already known
that non-insulin-dependent diabetes mellitus is often
associated with increased triglyceride, LDL-cholesterol
and a reduced HDL-cholesterol levels [26,27]. According
to the National Cholesterol education Program, high total
cholesterol is present in 70% of adults with diagnosed
diabetes and 77% with undiagnosed diabetes in the US
population [28]. All these findings demonstrate the rela-
tionship between diabetic status and hypercholestero-
lemia; however, the exact mechanisms that relate high
blood glucose levels to the incidence of hypercholestero-
lemia are not fully understood.
Finally, greater adherence to the Mediterranean diet was
inversely associated with the development of hypercho-
lesterolemia (Table 3). It is known that dietary habits usu-
ally influence blood lipids levels [29,30]. A traditional
dietary pattern that is often consumed in Mediterranean
populations has already been related to the reduction of
all cause and cardiovascular disease mortality, due to its
effect on blood pressure levels, body mass index, platelet
aggregation, plasma fibrinogen and other haemostaseo-
logical factors [31,32]. In this work it was observed a 6%
decrease in the risk of hypercholesterolemia per 1 unit
increase in the diet score that assessed adherence of the
Mediterranean diet, especially in middle aged women.
However, when the analysis was stratified by age and sex,
the aforementioned relationship was not significant in
men of any age and in older (>55 y) women, because of
the masking effect of other covariates included in the sta-
tistical models.
Limitations
The baseline evaluation was performed once, and may be
prone to measurement error. Thus, the prevalence of
hypercholesterolemia or the levels of total serum choles-
terol or other blood lipids, at baseline, may be overesti-
mated. However, our methodology is similar to those of
other cross – sectional surveys and follow-up epidemio-
logical studies in Europe and the US, and therefore the
results are comparable. The relative risks of developing
hypercholesterolemia were estimated by the odds ratios
through multiple logistic regression analysis, which may
lead to an overestimation of the true effect of the investi-
gated factors. Moreover, multiple significance tests were
performed (in Table 2) that may influenced the signifi-
cance of the findings; however, the results from the multi-
ple logistic regression analysis were the most reliable.
Another limitation is that we have not completed the die-
tary analysis for nutrient components (including electro-
lytes), so the role of specific nutrients was not evaluated.
Finally, telephone calls for the ascertainment of hypercho-
lesterolemia is valid only when accurate medical records
exist; therefore, we assessed the 5-year incidence of known
hypercholesterolemia and many individuals that devel-
oped hypercholesterolemia during the 5-year period, but
they did not know it, were misclassified in the re-exami-
nation.
Conclusion
The 5-year incidence of hypercholesterolemia in a popu-
lation-based sample of cardiovascular disease free adult
men and women was evaluated. Roughly one out of four
men and one out of five women developed hypercholes-
terolemia within this period. Age greater than 45 y, waist
circumference greater than 95/82 cm, fasting blood glu-
cose greater than 100 mg/dl and apolipoprotein B levels
greater than 100 mg/dl, were the most significant determi-
nants of hypercholesterolemia, irrespective of lifestyle
habits and other potential confounders. Moreover, adher-
ence to the Mediterranean diet seems to protect from
future development of hypercholesterolemia, especially
among women. The present work provides information
about the incidence rates of hypercholesterolemia and a
framework of primary prevention of this metabolic disor-
der at population level.
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